Laboratorios Farmaceuticos Rovi revenue and financials
In the fiscal year ended December 2025, Laboratorios Farmaceuticos Rovi reported revenue of €743.48M (−2.65% year over year). Net income was €140.44M, a net margin of 18.9%.
Fiscal year ending in December. Sources and method on the page How we analyse stocks.
At a glance
- Revenue growth
- −2.65%
- 2025 vs 2024
- Net income growth
- +2.60%
- 2025 vs 2024
- Net margin
- 18.9%
- 2024: 17.9%
How Laboratorios Farmaceuticos Rovi is changing
Calculated from the annual statements; each fiscal year is labelled with the year it ends.
Revenue grew 12.1% a year on average over the last 5 years
Compound annual growth rate: from €419.96M in 2020 to €743.48M in 2025.
Operating margin fell from 31.0% to 23.3%
Operating income over revenue, 2022 → 2025: 7.7 percentage points.
Less cash than profit: free cash flow equal to 58% of net income
Totals for fiscal years 2023–2025: free cash flow €260.48M, net income €447.66M.
Shares outstanding down 7.7% in 5 years
Average diluted shares, 2020 → 2025: with fewer shares, each one represents a larger stake in the company.
Financial data
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 743 | 764 | 830 | 818 | 649 | 420 | 381 | 303 | 276 | 265 |
| Cost of revenue | 272 | 296 | 346 | 305 | 269 | 183 | 170 | 132 | 114 | 115 |
| Gross profit | 472 | 468 | 483 | 512 | 380 | 237 | 211 | 171 | 162 | 150 |
| Selling, general and administrative | 160 | 158 | 147 | 130 | 103 | 84.8 | 92.2 | 91.1 | 84.6 | 80.1 |
| Operating income | 173 | 179 | 219 | 254 | 180 | 74.9 | 42.0 | 15.9 | 15.2 | 22.7 |
| EBIT | 173 | 179 | 219 | 254 | 180 | 74.9 | 42.0 | 15.9 | 15.2 | 22.7 |
| EBITDA | 196 | 200 | 238 | 271 | 197 | 89.6 | 55.4 | 27.0 | 25.4 | 32.6 |
| Interest expense | 2.6 | 2.0 | 0.9 | 0.8 | 0.9 | 1.1 | 0.6 | 0.7 | 1.0 | 0.9 |
| Pre-tax income | 183 | 178 | 220 | 258 | 183 | 72.6 | 41.9 | 16.7 | 17.5 | 27.9 |
| Income tax | 42.9 | 40.8 | 50.1 | 58.3 | 29.6 | 11.5 | 2.6 | -1.2 | 0.3 | 1.8 |
| Net income | 140 | 137 | 170 | 200 | 153 | 61.1 | 39.3 | 17.9 | 17.2 | 26.1 |
| Net income to common shareholders | 140 | 137 | 170 | 200 | 153 | 61.1 | 39.3 | 17.9 | 17.2 | 26.1 |
| Basic EPS | 2.75 | 2.67 | 3.20 | 3.73 | 2.76 | 1.10 | 0.71 | 0.35 | 0.35 | 0.53 |
| Diluted EPS | 2.75 | 2.67 | 3.20 | 3.73 | 2.76 | 1.10 | 0.71 | 0.35 | 0.35 | 0.53 |
| Average shares (basic) | 51.1 | 51.2 | 53.2 | 53.5 | 55.4 | 55.4 | 55.2 | 51.2 | 49.3 | 49.3 |
| Average shares (diluted) | 51.1 | 51.2 | 53.2 | 53.5 | 55.4 | 55.4 | 55.2 | 51.2 | 49.3 | 49.3 |
| Dividend per share | 0.96 | 0.94 | 1.10 | 1.29 | 0.96 | 0.38 | 0.18 | 0.08 | 0.12 | 0.18 |
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 192 | 152 | 218 | 210 | 160 | 155 | 199 | 235 | 178 | 151 | 235 | 214 |
| Cost of revenue | 60.0 | 59.6 | 90.3 | 62.7 | 54.4 | 64.5 | 90.7 | 72.0 | 67.8 | 65.5 | 105 | 77.8 |
| Gross profit | 132 | 92.9 | 128 | 148 | 105 | 90.4 | 108 | 163 | 110 | 85.7 | 130 | 136 |
| Selling, general and administrative | 47.2 | 38.0 | 55.4 | 34.7 | 35.3 | 35.1 | 60.2 | 33.2 | 32.6 | 32.3 | 56.5 | 31.4 |
| Operating income | 18.0 | 9.9 | 54.9 | 68.0 | 27.4 | 22.9 | 32.4 | 90.1 | 37.2 | 19.1 | 66.2 | 68.2 |
| EBIT | 18.0 | 9.9 | 54.9 | 68.0 | 27.4 | 22.9 | 32.4 | 90.1 | 37.2 | 19.1 | 66.2 | 68.2 |
| EBITDA | 23.6 | 18.1 | 55.1 | 79.2 | 31.1 | 30.1 | 32.7 | 101 | 40.6 | 25.7 | 67.0 | 76.9 |
| Interest expense | 2.0 | 0.8 | 0.8 | 0.8 | 0.7 | 0.6 | 0.6 | 1.0 | 0.3 | 0.3 | 1.7 | 0.2 |
| Pre-tax income | 89.3 | 12.3 | 57.9 | 75.7 | 26.8 | 22.8 | 32.2 | 89.4 | 37.1 | 19.0 | 66.2 | 68.3 |
| Income tax | 14.4 | 2.8 | 15.3 | 17.7 | 5.2 | 4.8 | 8.8 | 20.2 | 7.8 | 4.0 | 14.8 | 16.2 |
| Net income | 75.0 | 9.5 | 42.7 | 58.0 | 21.6 | 18.1 | 23.4 | 69.1 | 29.4 | 15.0 | 51.5 | 52.2 |
| Net income to common shareholders | 75.0 | 9.5 | 42.7 | 58.0 | 21.6 | 18.1 | 23.4 | 69.1 | 29.4 | 15.0 | 51.5 | 52.2 |
| Basic EPS | 1.47 | 0.19 | 0.83 | — | 0.42 | 0.35 | 0.46 | — | 0.55 | — | 0.99 | — |
| Diluted EPS | 1.47 | 0.19 | 0.83 | — | 0.42 | 0.35 | 0.46 | — | 0.55 | — | 0.99 | — |
| Average shares (basic) | 51.1 | 51.1 | 51.1 | — | 51.1 | 51.1 | 51.1 | — | 53.4 | — | 51.8 | — |
| Average shares (diluted) | 51.1 | 51.1 | 51.1 | — | 51.1 | 51.1 | 51.1 | — | 53.4 | — | 51.8 | — |
| Dividend per share | — | — | 0.96 | — | — | — | 0.94 | — | — | — | 1.10 | — |
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 956 | 832 | 800 | 879 | 733 | 574 | 511 | 403 | 298 | 288 |
| Current assets | 567 | 490 | 509 | 623 | 506 | 365 | 318 | 254 | 168 | 167 |
| Cash and equivalents | 98.0 | 27.2 | 25.3 | 125 | 99.0 | 53.2 | 67.4 | 95.5 | 40.7 | 41.4 |
| Short-term investments | 0.6 | 0.8 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 |
| Receivables | 175 | 127 | 140 | 181 | 158 | 82.0 | 90.0 | 62.0 | 50.6 | 56.7 |
| Inventory | 288 | 330 | 338 | 312 | 245 | 227 | 159 | 94.9 | 75.5 | 67.4 |
| Net property, plant and equipment | 331 | 287 | 254 | 216 | 182 | 155 | 132 | 95.8 | 89.1 | 82.8 |
| Goodwill | 2.7 | 0.0 | — | — | — | — | — | — | — | — |
| Other intangible assets | 33.2 | 34.0 | 27.7 | 29.1 | 31.5 | 33.9 | 37.2 | 26.3 | 18.6 | 20.6 |
| Long-term investments | 19.2 | 19.5 | 0.6 | 2.2 | 2.1 | 1.9 | 1.9 | 2.1 | 2.1 | 2.6 |
| Current liabilities | 181 | 157 | 200 | 294 | 190 | 123 | 107 | 87.5 | 73.2 | 76.4 |
| Accounts payable | 84.8 | 89.9 | 110 | 126 | 99.4 | 65.2 | 70.1 | 49.8 | 43.4 | 50.8 |
| Long-term debt | 83.9 | 80.5 | 38.6 | 46.0 | 52.5 | 53.9 | 54.7 | 16.6 | 27.0 | 20.8 |
| Total debt | 122 | 114 | 65.4 | 72.2 | 73.2 | 74.4 | 84.8 | 34.2 | 43.2 | 33.8 |
| Total liabilities | 280 | 250 | 256 | 357 | 262 | 201 | 189 | 115 | 107 | 104 |
| Total equity (incl. minority) | 675 | 582 | 543 | 521 | 471 | 374 | 322 | 287 | 192 | 183 |
| Retained earnings | 579 | 487 | 556 | 457 | 446 | 303 | 242 | 205 | 197 | 189 |
| Minority interest | 11.0 | 9.5 | 4.1 | 1.4 | — | — | — | — | — | — |
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 1,127 | 926 | 956 | 922 | 870 | 814 | 832 | 878 | 857 | 779 | 800 | 831 |
| Current assets | 568 | 539 | 567 | 559 | 516 | 468 | 490 | 554 | 541 | 485 | 509 | 567 |
| Cash and equivalents | 127 | 97.4 | 98.0 | 49.3 | 46.1 | 29.3 | 27.2 | 17.6 | 44.6 | 13.1 | 25.3 | 56.4 |
| Short-term investments | 1.1 | — | 0.6 | — | 1.6 | — | 0.8 | — | 0.5 | — | 0.1 | — |
| Receivables | 160 | 164 | 175 | 192 | 134 | 116 | 127 | 186 | 135 | 132 | 140 | 139 |
| Inventory | 273 | 274 | 288 | 315 | 328 | 319 | 330 | 347 | 355 | 338 | 338 | 366 |
| Net property, plant and equipment | 486 | 329 | 331 | 305 | 294 | 288 | 287 | 270 | 261 | 257 | 254 | 227 |
| Goodwill | 2.7 | 2.7 | 2.7 | — | 2.7 | — | — | — | — | — | — | — |
| Other intangible assets | 33.0 | 32.4 | 33.2 | 35.5 | 27.5 | 35.9 | 34.0 | 32.7 | 27.1 | 33.3 | 27.7 | 33.8 |
| Long-term investments | 19.3 | 19.2 | 19.2 | 19.1 | 19.0 | 19.0 | 19.5 | 19.6 | 19.6 | 0.8 | 0.6 | 2.7 |
| Current liabilities | 277 | 148 | 181 | 185 | 187 | 126 | 157 | 221 | 272 | 191 | 200 | 221 |
| Accounts payable | 73.0 | 75.8 | 84.8 | 102 | 57.2 | 90.8 | 89.9 | 124 | 102 | 107 | 110 | 114 |
| Long-term debt | 80.5 | 72.6 | 83.9 | 85.1 | 101 | 70.7 | 80.5 | 78.2 | 80.7 | 59.6 | 38.6 | 37.2 |
| Total debt | 108 | 114 | 122 | 124 | 129 | 108 | 114 | 128 | 121 | 81.8 | — | — |
| Total liabilities | 410 | 240 | 280 | 289 | 295 | 214 | 250 | 320 | 375 | 255 | 256 | 276 |
| Total equity (incl. minority) | 717 | 687 | 675 | 633 | 575 | 599 | 582 | 558 | 483 | 524 | 543 | 555 |
| Retained earnings | 614 | 590 | 579 | 536 | 478 | 504 | 487 | 464 | 543 | 571 | 556 | 505 |
| Minority interest | 16.4 | 12.8 | 11.0 | 11.1 | 11.1 | 9.6 | 9.5 | 9.5 | 6.7 | 4.1 | 4.1 | 3.1 |
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 187 | 138 | 113 | 238 | 149 | 46.9 | -9.0 | 8.5 | 18.0 | 45.5 |
| Depreciation and amortization | 28.8 | 26.9 | 23.4 | 21.8 | 20.3 | 18.3 | 17.0 | 11.1 | 10.2 | 9.9 |
| Capital expenditure | -65.2 | -59.1 | -53.8 | -50.7 | -40.2 | -39.3 | -25.9 | -16.4 | -14.9 | -9.7 |
| Investing cash flow | -68.5 | -81.1 | -52.0 | -57.2 | -40.8 | -39.6 | -40.5 | -26.2 | -19.2 | -16.3 |
| Financing cash flow | -47.8 | -55.4 | -161 | -155 | -62.7 | -21.5 | 21.4 | 72.5 | 0.5 | -17.1 |
| Dividends paid | -47.8 | -56.5 | -69.0 | -51.0 | -21.1 | -9.7 | -4.4 | -6.0 | -9.0 | -7.0 |
| Share repurchases | -54.9 | -89.7 | -134 | -177 | -78.8 | -37.3 | -4.7 | -1.1 | -0.5 | -1.0 |
| Debt issued | 47.6 | 97.0 | 0.7 | 1.4 | 1.3 | 1.4 | 47.0 | 7.0 | 22.4 | 0.8 |
| Debt repaid | -46.8 | -51.7 | -13.7 | -6.8 | -6.2 | -13.2 | -21.2 | -16.2 | -13.1 | -10.3 |
| Net change in cash | 70.8 | 1.9 | -99.6 | 25.9 | 45.9 | -14.3 | -28.1 | 54.8 | -0.7 | 12.1 |
| Free cash flow | 122 | 79.2 | 59.5 | 187 | 109 | — | — | — | — | — |
| Levered free cash flow | 82.3 | 44.9 | 25.4 | 136 | 66.2 | -12.1 | -64.3 | -23.1 | -7.8 | 20.1 |
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 81.3 | 13.0 | 85.7 | 73.4 | 9.2 | 18.8 | 73.1 | 35.4 | 14.2 | 15.5 | 61.0 | -0.3 |
| Depreciation and amortization | 8.7 | 8.2 | 6.5 | 8.2 | 6.7 | 7.3 | 6.3 | 7.7 | 6.3 | 6.6 | 5.6 | 6.4 |
| Capital expenditure | -21.4 | -7.5 | -28.1 | -17.0 | -12.1 | -8.1 | -26.3 | -14.8 | -9.2 | -8.9 | -27.5 | -8.3 |
| Investing cash flow | -46.3 | -7.4 | -27.0 | -17.5 | -10.3 | -11.6 | -47.2 | -15.2 | -9.6 | -9.2 | -26.3 | -8.4 |
| Financing cash flow | -5.5 | -6.2 | -7.9 | -52.7 | 19.8 | -7.0 | -16.3 | -47.3 | 26.9 | -18.6 | -65.8 | -88.8 |
| Dividends paid | — | — | 0.0 | -47.8 | — | — | 0.0 | -56.5 | — | — | — | -69.0 |
| Share repurchases | -17.8 | -21.5 | -10.1 | -16.4 | -13.7 | -14.7 | -19.0 | -18.6 | -17.5 | -34.7 | -63.0 | -22.2 |
| Debt issued | — | — | 0.0 | 1.1 | 46.5 | 0.0 | 12.3 | 14.5 | 50.6 | 19.6 | 0.1 | — |
| Debt repaid | -7.1 | -7.3 | -7.4 | -6.9 | -26.4 | -6.2 | -27.9 | -7.7 | -12.7 | -3.5 | -3.8 | -3.0 |
| Effect of exchange rates | 0.1 | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | 29.6 | -0.6 | 48.7 | 3.1 | 16.8 | 2.1 | 9.6 | -27.0 | 31.5 | -12.2 | -31.1 | -97.4 |
| Free cash flow | 59.9 | 5.5 | 57.6 | 56.4 | -2.9 | 10.8 | 46.8 | 20.7 | 5.0 | 6.7 | 33.5 | -8.6 |
| Levered free cash flow | 129 | -0.5 | 48.0 | -8.9 | 36.9 | 6.1 | 19.1 | -54.9 | 77.2 | 3.4 | 22.7 | -88.9 |
Financial statements of similar companies
Companies in the group: same industry, similar size
